NCT02688374View on ClinicalTrials.gov

A Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and One Reference) in Healthy Adult Smokers

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 11, 2016

Primary Completion Date

June 12, 2016

Study Completion Date

June 12, 2016

Conditions
Tobacco Use Disorder
Interventions
OTHER

Treatment A: Nicorette 2 mg coated mint gum

Participants will be administered with 2 mg coated mint gum of Nicorette

OTHER

Treatment B: Nicotinell 2 mg coated mint gum

Participants will be administered with 2 mg coated mint gum of Nicotinell

OTHER

Treatment C: Nicotinell 2 mg coated fruit flavor gum

Participants will be administered with 2 mg coated fruit flavor gum of Nicotinell

Trial Locations (1)

100032

GSK Investigational Site, Beijing

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02688374 - A Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and One Reference) in Healthy Adult Smokers | Biotech Hunter | Biotech Hunter